Rayk Behrendt receives ERC Consolidator Grant

- EN - DE

The ERC is funding the Professor for Nucleic Acid Immunity at the University of Bonn with around 2 million euros

Rayk Behrendt - from the Institute for Clinical Chemistry and Clinical Pharmacol
Rayk Behrendt - from the Institute for Clinical Chemistry and Clinical Pharmacology of the University Hospital Bonn © David Fußhöller / University Hospital Bonn .

The human genome harbors large segments that offer no obvious benefit and can potentially even cause disease. Nevertheless, these areas are copied and maintained every time a cell divides, which means a considerable effort and energy cost for the body. What is the evolutionary advantage of preserving these areas? This is the question that virologist and immunologist Prof. Rayk Behrendt from the Cluster of Excellence ImmunoSensation2 at the University of Bonn is addressing. For his research, he now receives the prestigious Consolidator Grant of the European Research Council (ERC). ...

account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.